Unravelling the Mechanism of Fdc1, a Novel Prfmn Dependent Decarboxylase

Total Page:16

File Type:pdf, Size:1020Kb

Unravelling the Mechanism of Fdc1, a Novel Prfmn Dependent Decarboxylase Unravelling the Mechanism of Fdc1, a Novel prFMN Dependent Decarboxylase A thesis submitted to the University of Manchester for the degree of Doctor in Philosophy (PhD) in the Faculty of Science and Engineering School of Chemistry Samuel S. Bailey 2018 Table of Contents 1 Abstract and Preface 0 1.1 Abstract 0 1.2 Declaration 1 1.3 Copyright Statement 1 1.4 Acknowledgments 2 1.5 Preface to Journal Format 3 2 Introduction 5 2.1 Project Outline 5 2.2 Biofuels 5 2.2.1 Second generation biofuels 6 2.3 Flavoenzymes 7 2.3.1 Covalent Modifications of Flavins 9 2.3.2 The Reactions of Flavin with Oxygen 10 2.4 Diels-Alderases: [4+2] Cycloaddition in Natural Product Biosynthesis 12 2.4.1 Artificial Diels-Alderases 13 2.4.2 Natural Diels-Alderases 13 2.5 The Role of Substrate Strain in Enzymatic Catalysis 14 2.5.1 Substrate Strain in Chelatases 15 2.5.2 Substrate Strain in Lysozyme 15 2.5.3 Substrate Strain in Human Transketolase 16 2.6 Enzymatic Decarboxylation 18 2.6.1 Cofactor Independent Decarboxylases 18 2.6.2 Thiamine Pyrophosphate (TPP) Dependent Decarboxylases 20 2.6.3 Pyridoxal 5’-phosphate (PLP) Dependent Decarboxylases 20 2.6.4 Flavin dependent decarboxylases 21 2.7 The UbiX/UbiD and Pad/Fdc systems 22 2.7.1 UbiX is responsible for the synthesis of a novel flavin cofactor 23 2.7.2 Fdc1 uses prFMN for decarboxylation 26 2.7.3 The structure of A. niger Fdc1 27 2.7.4 Proposed Mechanism of Decarboxylation by Fdc1 27 2.8 Other UbiD enzymes 29 1 2.8.1 The UbiD Superfamily 29 2.8.2 Common themes among the UbiD superfamily 31 2.9 Unravelling the UbiD mechanism: Fdc1 as a model system 31 2.9.1 Fdc1 Cofactor maturation 31 2.9.2 Mechanism of Decarboxylation 32 2.9.3 The ERE motif 32 2.10 Aims 33 2.11 References 33 3 The role of conserved residues in UbiD/Fdc decarboxylase in oxidative maturation, isomerisation and catalysis of prenylated flavin mononucleotide 46 3.1 Abstract 47 3.2 Introduction 47 3.3 Results 50 3.3.1 Light-dependent cofactor isomerization and enzyme inactivation 50 3.3.2 UV-vis spectrophotometric characterization of Fdc1 E277 and E282 variants reveal minor variation in prFMN incorporation and maturation 52 3.3.3 An acidic residue at both position 277 and 282 is required for activity 54 3.3.4 Enzyme catalysed styrene H/D exchange confirms the need for acidic residues at 277 and 282 55 3.3.5 Light-dependent cofactor isomerization is not dependent on the E-R- E motif 58 3.3.6 R173 variants reveal deficiencies in cofactor maturation 58 3.3.7 Crystal structure of R173A confirms cofactor maturation occurs over longer timescales 61 3.3.8 Crystal structures of Fdc1 E282 variants reveal minor structural variation 62 3.3.9 Crystal structures of Fdc1 E277 variants reveal significant C1’ adduct formation 63 3.3.10 Similar trends are observed for Saccharomyces cerevisiae Fdc1 variants 64 2 3.4 Discussion 67 3.5 Experimental Procedures 71 3.5.1 Cloning 71 3.5.2 Mutagenesis 71 3.5.3 Protein expression 71 3.5.4 Purification of A. niger Fdc1 71 3.5.5 Purification of S. cerevisiae Fdc1 72 3.5.6 In vitro reconstitution of apo-Fdc1 72 3.5.7 UV-visible spectroscopy and protein quantification 72 3.5.8 UV-visible spectrophotometric decarboxylation assays 72 3.5.9 Light/dark studies 73 3.5.10 Hydrogen/Deuterium exchange assays 73 3.5.11 HPLC decarboxylation assays 73 3.5.12 Protein crystallization and structure determination 73 3.5.13 EPR and ENDOR spectroscopy 76 3.5.14 Mass Spectrometry 76 3.6 References 76 4 Atomic description of an enzyme reaction dependent on reversible 1,3-dipolar cycloaddition 80 4.1 Abstract 81 4.2 Introduction 81 4.3 Results and Discussion 83 4.4 Methods 95 4.4.1 Cloning 95 4.4.2 Mutagenesis 95 4.4.3 Protein Expression 95 4.4.4 Protein Purification 95 4.4.5 UV-vis spectroscopy 96 4.4.6 UV-vis decarboxylation assays 96 4.4.7 Stopped-flow 96 4.4.8 Protein crystallization and structure determination 97 4.4.9 Production and crystallisation of FMN containing A. niger Fdc1 99 3 4.4.10 Crystallisation of A. niger Fdc1 containing prFMN-crotonic acid adduct 99 4.4.11 HPLC decarboxylation assays 99 4.4.12 Cofactor Mass Spectrometry 100 4.4.13 Protein Mass Spectrometry 100 4.5 References 100 5 Discussion 104 5.1 prFMNiminium is the active form of the cofactor 104 5.2 The mechanism of prFMN oxidative maturation 105 5.3 The mechanism of Decarboxylation by Fdc1 106 5.4 Outstanding Prospects in UbiD Biochemistry 110 5.5 Final remarks 112 5.6 References 112 6 Appendix 117 6.1 Published Paper: “The role of conserved residues in UbiD/Fdc decarboxylase in oxidative maturation, isomerisation and catalysis of prenylated flavin mononucleotide” 117 6.2 List of abbreviations 134 4 Table of figures and tables Chapter 2 Figure 1. General flavochemistry 8 Figure 2. General scheme for a diels-alderase catalysed [4+2] cycloaddition 12 Figure 3. The effect of enzymatic strain on the energy of the enzyme substrate and enzyme-transition state complex 14 Figure 4. Mesoporphyrin ring 15 Figure 5. A representation of a NAM sugar residue in the chair (a) and sofa (b) conformations 16 Figure 6. Crystal structure of the covalent D-xyulose-5-phosphate (X5P)-TDP intermediate in Transkelotase 18 Figure 7. Cofactor Independent Decarboxylations 19 Figure 8. A general mechanism for Thiamine Pyrophosphate (TPP) dependent decarboxylation 20 Figure 9. A general mechanism for Pyridoxal 5’-phosphate (PLP) dependent decarboxylation 21 Figure 10. A general mechanism for FMN dependent decarboxylation 22 Figure 11. UbiX overview 24 Figure 12. Fdc1 overview 26 Chapter 3 Figure 1. Overview of prFMN maturation and catalysis in Fdc1 48 Figure 2. Effect of illumination on A. niger Fdc1 activity 51 Figure 3. UV-visible spectra for A. niger Fdc1 variants 52 Figure 4. prFMN mass spectrometry and maturation mechanism 53 Figure 5. Detection of decarboxylation activity using HPLC 54 Figure 6. Characterization of the active variants E282D and E277D 55 Figure 7. H/D exchange of styrene 57 Figure 8. UV-induced tautomerisation of prFMNiminium to prFMNketimine 58 Figure 9. UV-Visible absorbance, EPR and ENDOR spectra of prFMN- reconstituted Fdc1 R173A and as purified Fdc1 R173A 60 Figure 10. Crystal structures of Fdc1 variants in complex with prFMN 62 0 Figure 11. UV-visible spectra and kinetic analysis for S. cerevisiae Fdc1 mutants 65 Figure 12. Crystal structures of S. cerevisiae Fdc1 variants in complex with prFMN 66 Figure 13. Proposed mechanism for maturation of prFMNreduced to prFMNiminium in Fdc1 69 Chapter 4 Figure 1. A. niger Fdc proposed enzyme mechanism 82 Figure 2. Crystal structures of A. niger Fdc with alkene substrates 83 Figure 3. Crystal structures of wild-type A. niger Fdc with various substrate analogues 84 Figure 4. UV-Visible spectra for A. niger with substrate analogues and HPLC activity assay 85 Figure 5. Stopped-flow traces and concentration profiles for A. niger Fdc1 with substrate analogues 86 Figure 6. Crystal structures of A. niger Fdc with alkyn substrate analogues 87 Figure 7. Mass spectrometry of prFMN-cycloadducts extracted from A. niger Fdc1 88 Figure 8. Solution studies and crystal structures for A. niger Fdc1 variants 90 Figure 9. A schematic overview illustrating the role of strain in the Fdc reaction 93 Chapter 5 Figure 1. The expanding prFMN chemical repertoire 105 Figure 2. Overview of the UbiD enzyme family 109 1 1 Abstract and Preface 1.1 Abstract The UbiD superfamily of enzymes are reversible decarboxylases that depend on the novel cofactor prenylated FMN (prFMN) for activity. The partner protein UbiX prenylates FMNH2 using dimethylallyl phosphate. The UbiX product, prFMNH2 is then passed to UbiD, where oxidative maturation to an active form, prFMNiminium occurs. Following oxidative activation, UbiD family members are able to catalyse the reversible decarboxylation of a wide range of unsaturated aliphatic and aromatic acids. The UbiD family contain a conserved active site E(D)RE motif that is proposed to play a role in cofactor maturation and decarboxylation. The Fdc1 enzyme from Aspergillus niger catalyses the decarboxylation of cinnamic acid and acts as a model system for studying UbiD enzymes, due to its amenability to high resolution crystallographic studies, ease of purification and readily detectable decarboxylation activity. Our studies on Fdc1 provide valuable insights into the role of the conserved ERE motif in cofactor maturation, isomerisation, and substrate (de)carboxylation. We confirm prFMNiminium is the active form, with illumination leading to inactivation through formation of the prFMNketimine isomer. We demonstrate ERE predominantly acts in catalysis, but not maturation or isomerisation. Our crystallographic studies of Fdc1 in complex with alkene substrates and alkyne inhibitors provides the first direct evidence for enzymatic 1,3-dipolar cycloaddition. These crystal structures also demonstrate a crucial role for molecular strain, whereby the enzyme is able to achieve reversible cycloaddition through selective destabilisation of key intermediates. Hence, we present strong evidence for the proposed 1,3-dipolar cycloaddition mechanism in case of enoic acid substrates. This leads to the question whether a similar mechanism also applies in case of aromatic acids, as occurs in distinct branches of the UbiD family. This remains a contentious issue, and will require future studies on distinct representatives of the UbiD-superfamily.
Recommended publications
  • Kenneth M. Roberts
    Kenneth M. Roberts Assistant Professor of Chemistry Department of Chemistry and Physics University of South Carolina Aiken SBDG 322A 471 University Parkway Aiken, SC 29801 (803) 641-3561 [email protected] EDUCATION and EXPERIENCE Aug 2015 - present Assistant Professor University of South Carolina Courses: Introductory Chemistry (CHEM A101) Aiken General Chemistry (CHEM A111, A112) Organic Chemistry (CHEM A331L, A332L) Biochemistry (BIOL A541, CHEM A550) Research: Investigating the mechanisms of the metal-dependent enzymes 2,4’-dihydroxyacetophenone dioxygenase and gallate decarboxylase Fall 2012 - Spring 2014 Adjunct Professor Fall 2011 General Chemistry (CH 1401 and 1402) St. Mary’s University Organic Chemistry (CH 3411 and 3412) 80 contact hours: lecture 100 contact hours: laboratory Apr 2010 – Jul 2015 Post-Doctoral Associate, Department of Biochemistry University of Texas Health Focus: Investigation of the mechanism of the aromatic amino acid Science Center at San Antonio hydroxylases using rapid-reaction techniques. Advisor: Dr. Paul F. Fitzpatrick Dec 2009 - Mar 2010 Post-Doctoral Associate, Department of Chemistry Washington State University Focus: Investigation of the mechanism of benzylic hydroxylation and N-dealkylation in a key catalytic mutant of cytochrome P450. Advisor: Dr. Jeffrey P. Jones Dec 2009 Ph.D. Biochemistry Washington State University Thesis: Mechanistic evaluation of N-dealkylation by cytochrome P450 using N,N-dimethylaniline N-oxides and kinetic isotope effects Advisor: Dr. Jeffrey P. Jones Summer 2008 Lecturer/Teaching Assistant Washington State University Chemistry Related to Life Sciences (CHEM 102) 40 contact hours Mar 1996 B.S. Biochemistry University of Washington PUBLICATIONS *denotes undergraduate researchers Roberts, K. M., Connor, G. C.*, Cave, C. H.*, Rowe, G.
    [Show full text]
  • Arginine Enzymatic Deprivation and Diet Restriction for Cancer Treatment
    Brazilian Journal of Pharmaceutical Sciences Review http://dx.doi.org/10.1590/s2175-97902017000300200 Arginine enzymatic deprivation and diet restriction for cancer treatment Wissam Zam* Al-Andalus University for Medical Sciences, Faculty of Pharmacy, Analytical and Food Chemistry, Tartous, Syrian Arab Republic Recent findings in amino acid metabolism and the differences between normal, healthy cells and neoplastic cells have revealed that targeting single amino acid metabolic enzymes in cancer therapy is a promising strategy for the development of novel therapeutic agents. Arginine is derived from dietary protein intake, body protein breakdown, or endogenous de novo arginine production and several studies have revealed disturbances in its synthesis and metabolism which could enhance or inhibit tumor cell growth. Consequently, there has been an increased interest in the arginine-depleting enzymes and dietary deprivation of arginine and its precursors as a potential antineoplastic therapy. This review outlines the most recent advances in targeting arginine metabolic pathways in cancer therapy and the different chemo- and radio-therapeutic approaches to be co-applied. Key words: Arginine-depleting enzyme/antineoplastic therapy. Dietary deprivation. INTRODUCTION variety of human cancer cells have been found to be auxotrophic for arginine, depletion of which results in Certain cancers may be auxotrophic for a particular cell death (Tytell, Neuman, 1960; Kraemer, 1964; Dillon amino acid, and amino acid deprivation is one method to et al., 2004). Arginine can be degraded by three enzymes: treat these tumors. The strategy of enzymatic degradation arginase, arginine decarboxylase and arginine deiminase of amino acids to deprive malignant cells of important (ADI). Both arginine decarboxylase and ADI are not nutrients is an established component of induction therapy expressed in mammalian cells (Morris, 2007; Miyazaki of several tumor cells.
    [Show full text]
  • (10) Patent No.: US 8119385 B2
    US008119385B2 (12) United States Patent (10) Patent No.: US 8,119,385 B2 Mathur et al. (45) Date of Patent: Feb. 21, 2012 (54) NUCLEICACIDS AND PROTEINS AND (52) U.S. Cl. ........................................ 435/212:530/350 METHODS FOR MAKING AND USING THEMI (58) Field of Classification Search ........................ None (75) Inventors: Eric J. Mathur, San Diego, CA (US); See application file for complete search history. Cathy Chang, San Diego, CA (US) (56) References Cited (73) Assignee: BP Corporation North America Inc., Houston, TX (US) OTHER PUBLICATIONS c Mount, Bioinformatics, Cold Spring Harbor Press, Cold Spring Har (*) Notice: Subject to any disclaimer, the term of this bor New York, 2001, pp. 382-393.* patent is extended or adjusted under 35 Spencer et al., “Whole-Genome Sequence Variation among Multiple U.S.C. 154(b) by 689 days. Isolates of Pseudomonas aeruginosa” J. Bacteriol. (2003) 185: 1316 1325. (21) Appl. No.: 11/817,403 Database Sequence GenBank Accession No. BZ569932 Dec. 17. 1-1. 2002. (22) PCT Fled: Mar. 3, 2006 Omiecinski et al., “Epoxide Hydrolase-Polymorphism and role in (86). PCT No.: PCT/US2OO6/OOT642 toxicology” Toxicol. Lett. (2000) 1.12: 365-370. S371 (c)(1), * cited by examiner (2), (4) Date: May 7, 2008 Primary Examiner — James Martinell (87) PCT Pub. No.: WO2006/096527 (74) Attorney, Agent, or Firm — Kalim S. Fuzail PCT Pub. Date: Sep. 14, 2006 (57) ABSTRACT (65) Prior Publication Data The invention provides polypeptides, including enzymes, structural proteins and binding proteins, polynucleotides US 201O/OO11456A1 Jan. 14, 2010 encoding these polypeptides, and methods of making and using these polynucleotides and polypeptides.
    [Show full text]
  • The Microbiota-Produced N-Formyl Peptide Fmlf Promotes Obesity-Induced Glucose
    Page 1 of 230 Diabetes Title: The microbiota-produced N-formyl peptide fMLF promotes obesity-induced glucose intolerance Joshua Wollam1, Matthew Riopel1, Yong-Jiang Xu1,2, Andrew M. F. Johnson1, Jachelle M. Ofrecio1, Wei Ying1, Dalila El Ouarrat1, Luisa S. Chan3, Andrew W. Han3, Nadir A. Mahmood3, Caitlin N. Ryan3, Yun Sok Lee1, Jeramie D. Watrous1,2, Mahendra D. Chordia4, Dongfeng Pan4, Mohit Jain1,2, Jerrold M. Olefsky1 * Affiliations: 1 Division of Endocrinology & Metabolism, Department of Medicine, University of California, San Diego, La Jolla, California, USA. 2 Department of Pharmacology, University of California, San Diego, La Jolla, California, USA. 3 Second Genome, Inc., South San Francisco, California, USA. 4 Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA, USA. * Correspondence to: 858-534-2230, [email protected] Word Count: 4749 Figures: 6 Supplemental Figures: 11 Supplemental Tables: 5 1 Diabetes Publish Ahead of Print, published online April 22, 2019 Diabetes Page 2 of 230 ABSTRACT The composition of the gastrointestinal (GI) microbiota and associated metabolites changes dramatically with diet and the development of obesity. Although many correlations have been described, specific mechanistic links between these changes and glucose homeostasis remain to be defined. Here we show that blood and intestinal levels of the microbiota-produced N-formyl peptide, formyl-methionyl-leucyl-phenylalanine (fMLF), are elevated in high fat diet (HFD)- induced obese mice. Genetic or pharmacological inhibition of the N-formyl peptide receptor Fpr1 leads to increased insulin levels and improved glucose tolerance, dependent upon glucagon- like peptide-1 (GLP-1). Obese Fpr1-knockout (Fpr1-KO) mice also display an altered microbiome, exemplifying the dynamic relationship between host metabolism and microbiota.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2009/0292100 A1 Fiene Et Al
    US 20090292100A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2009/0292100 A1 Fiene et al. (43) Pub. Date: Nov. 26, 2009 (54) PROCESS FOR PREPARING (86). PCT No.: PCT/EP07/57646 PENTAMETHYLENE 1.5-DIISOCYANATE S371 (c)(1), (75) Inventors: Martin Fiene, Niederkirchen (DE): (2), (4) Date: Jan. 9, 2009 (DE);Eckhard Wolfgang Stroefer, Siegel, Mannheim (30) Foreign ApplicationO O Priority Data Limburgerhof (DE); Stephan Aug. 1, 2006 (EP) .................................. O61182.56.4 Freyer, Neustadt (DE); Oskar Zelder, Speyer (DE); Gerhard Publication Classification Schulz, Bad Duerkheim (DE) (51) Int. Cl. Correspondence Address: CSG 18/00 (2006.01) OBLON, SPIVAK, MCCLELLAND MAIER & CD7C 263/2 (2006.01) NEUSTADT, L.L.P. CI2P I3/00 (2006.01) 194O DUKE STREET CD7C 263/10 (2006.01) ALEXANDRIA, VA 22314 (US) (52) U.S. Cl. ........... 528/85; 560/348; 435/128; 560/347; 560/355 (73) Assignee: BASFSE, LUDWIGSHAFEN (DE) (57) ABSTRACT (21) Appl. No.: 12/373,088 The present invention relates to a process for preparing pen tamethylene 1,5-diisocyanate, to pentamethylene 1,5-diiso (22) PCT Filed: Jul. 25, 2007 cyanate prepared in this way and to the use thereof. US 2009/0292100 A1 Nov. 26, 2009 PROCESS FOR PREPARING ene diisocyanates, especially pentamethylene 1,4-diisocyan PENTAMETHYLENE 1.5-DIISOCYANATE ate. Depending on its preparation, this proportion may be up to several % by weight. 0014. The pentamethylene 1,5-diisocyanate prepared in 0001. The present invention relates to a process for pre accordance with the invention has, in contrast, a proportion of paring pentamethylene 1,5-diisocyanate, to pentamethylene the branched pentamethylene diisocyanate isomers of in each 1.5-diisocyanate prepared in this way and to the use thereof.
    [Show full text]
  • Supplementary Informations SI2. Supplementary Table 1
    Supplementary Informations SI2. Supplementary Table 1. M9, soil, and rhizosphere media composition. LB in Compound Name Exchange Reaction LB in soil LBin M9 rhizosphere H2O EX_cpd00001_e0 -15 -15 -10 O2 EX_cpd00007_e0 -15 -15 -10 Phosphate EX_cpd00009_e0 -15 -15 -10 CO2 EX_cpd00011_e0 -15 -15 0 Ammonia EX_cpd00013_e0 -7.5 -7.5 -10 L-glutamate EX_cpd00023_e0 0 -0.0283302 0 D-glucose EX_cpd00027_e0 -0.61972444 -0.04098397 0 Mn2 EX_cpd00030_e0 -15 -15 -10 Glycine EX_cpd00033_e0 -0.0068175 -0.00693094 0 Zn2 EX_cpd00034_e0 -15 -15 -10 L-alanine EX_cpd00035_e0 -0.02780553 -0.00823049 0 Succinate EX_cpd00036_e0 -0.0056245 -0.12240603 0 L-lysine EX_cpd00039_e0 0 -10 0 L-aspartate EX_cpd00041_e0 0 -0.03205557 0 Sulfate EX_cpd00048_e0 -15 -15 -10 L-arginine EX_cpd00051_e0 -0.0068175 -0.00948672 0 L-serine EX_cpd00054_e0 0 -0.01004986 0 Cu2+ EX_cpd00058_e0 -15 -15 -10 Ca2+ EX_cpd00063_e0 -15 -100 -10 L-ornithine EX_cpd00064_e0 -0.0068175 -0.00831712 0 H+ EX_cpd00067_e0 -15 -15 -10 L-tyrosine EX_cpd00069_e0 -0.0068175 -0.00233919 0 Sucrose EX_cpd00076_e0 0 -0.02049199 0 L-cysteine EX_cpd00084_e0 -0.0068175 0 0 Cl- EX_cpd00099_e0 -15 -15 -10 Glycerol EX_cpd00100_e0 0 0 -10 Biotin EX_cpd00104_e0 -15 -15 0 D-ribose EX_cpd00105_e0 -0.01862144 0 0 L-leucine EX_cpd00107_e0 -0.03596182 -0.00303228 0 D-galactose EX_cpd00108_e0 -0.25290619 -0.18317325 0 L-histidine EX_cpd00119_e0 -0.0068175 -0.00506825 0 L-proline EX_cpd00129_e0 -0.01102953 0 0 L-malate EX_cpd00130_e0 -0.03649016 -0.79413596 0 D-mannose EX_cpd00138_e0 -0.2540567 -0.05436649 0 Co2 EX_cpd00149_e0
    [Show full text]
  • Potential Pharmacological Applications of Enzymes Associated with Bacterial Metabolism of Aromatic Compounds
    Vol. 9(1), pp. 1-13, January 2017 DOI: 10.5897/JMA2015.0354 Article Number: BD2460762280 ISSN 2141-2308 Journal of Microbiology and Antimicrobials Copyright © 2017 Author(s) retain the copyright of this article http://www.academicjournals.org/JMA Review Potential pharmacological applications of enzymes associated with bacterial metabolism of aromatic compounds Ranjith N. Kumavath1*, Debmalya Barh2, Vasco Azevedo3 and Alan Prem Kumar 4,5,6,7** 1Department of Genomic Sciences, School of Biological Sciences, Central University of Kerala, P.O. Central University, Kasaragod- 671314, India. 2Centre for Genomics and Applied Gene Technology, Institute of Integrative Omics and Applied Biotechnology, Nonakuri, PurbaMedinipur, West Bengal 721172, India. 3 Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais. MG, Brazil 4 Cancer Science Institute of Singapore, National University of Singapore, Singapore 5Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. 6Curtin Medical School, Faculty of Health Sciences, Curtin University, Perth, Western Australia. 7 Department of Biological Sciences, University of North Texas, Denton, TX, USA. Received 30 September, 2015; Accepted 3 January, 2016 Many purple anoxygenic bacteria contribute significantly to the catabolic and anabolic processes in the oxic/anoxic zones of several ecosystems. However, these bacteria are incapable of degrading the benzenoid ring during the biotransformation of aromatic hydrocarbons. The key enzymes in the aromatic
    [Show full text]
  • NIH Public Access Author Manuscript Curr Opin Chem Biol
    NIH Public Access Author Manuscript Curr Opin Chem Biol. Author manuscript; available in PMC 2010 October 1. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Curr Opin Chem Biol. 2009 October ; 13(4): 468±476. doi:10.1016/j.cbpa.2009.06.023. Pyridoxal 5'-Phosphate: Electrophilic Catalyst Extraordinaire John P. Richard†,*, Tina L. Amyes†, Juan Crugeiras#, and Ana Rios# †Department of Chemistry, University at Buffalo, SUNY, Buffalo, NY 14260-3000, USA. #Departamento de Química Física, Facultad de Química, Universidad de Santiago, 15782 Santiago de Compostela, Spain. Abstract Studies of nonenzymatic electrophilic catalysis of carbon deprotonation of glycine show that pyridoxal 5'-phosphate (PLP) strongly enhances the carbon acidity of α-amino acids, but that this is not the overriding mechanistic imperative for cofactor catalysis. Although the fully protonated PLP-glycine iminium ion adduct exhibits an extraordinary low α-imino carbon acidity (pKa = 6), the more weakly acidic zwitterionic iminium ion adduct (pKa = 17) is selected for use in enzymatic reactions. The similar α-imino carbon acidities of the iminium ion adducts of glycine with 5'- deoxypyridoxal and with phenylglyoxylate shows that the cofactor pyridine nitrogen plays a relatively minor role in carbanion stabilization. The 5'-phosphodianion group of PLP likely plays an important role in catalysis by providing up to 12 kcal/mol of binding energy that may be utilized for transition state stabilization. Introduction Scientists prize the rush of adrenalin that comes with making an original discovery, or with bringing order to seemingly disconnected experimental observations. Snell and Braunstein must have received tremendous satisfaction from their independent discovery, more than sixty years ago, that heating pyridoxal 5'-phosphate (PLP) with an amino acid yields the products of transamination of the amino acid [1].
    [Show full text]
  • Fmicb-07-01854
    Temporal Metagenomic and Metabolomic Characterization of Fresh Perennial Ryegrass Degradation by Rumen Bacteria Mayorga, O. L., Kingston-Smith, A. H., Kim, E. J., Allison, G. G., Wilkinson, T. J., Hegarty, M. J., Theodorou, M. K., Newbold, C. J., & Huws, S. A. (2016). Temporal Metagenomic and Metabolomic Characterization of Fresh Perennial Ryegrass Degradation by Rumen Bacteria. Frontiers in Microbiology, 7, 1854. https://doi.org/10.3389/fmicb.2016.01854 Published in: Frontiers in Microbiology Document Version: Publisher's PDF, also known as Version of record Queen's University Belfast - Research Portal: Link to publication record in Queen's University Belfast Research Portal Publisher rights Copyright 2017 the authors. This is an open access article published under a Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited. General rights Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the Research Portal that you believe breaches copyright or violates any law, please contact [email protected]. Download date:07.
    [Show full text]
  • Theory of Transition State
    Rational Drug Design lecture 8 Łukasz Berlicki Theory of transition state Transition state - the state with the highest potential energy on the reaction path. Activation energy - energy difference between substrates and transition state. It affects the reaction speed (k) - the Arrenius equation. k = Ae-Ea/RT 1 Enzymes The increase in reaction rate (kcat / knon ) obtained by enzymes is in the range of: 7 19 10 - 10 . ADC = arginine decarboxylase; ODC = orotidine 5¢-phosphate decarboxylase; STN = staphylococcal nuclease; GLU = sweet potato alpha -amylase; FUM = fumarase; MAN = mandelate racemase; PEP = carboxypeptidase B; CDA = E. coli cytidine deaminase; KSI = ketosteroid isomerase; CMU = chorismate mutase; CAN =carbonic anhydrase. Enzymatic catalysis Linus Pauling suggested that the efficiency of enzymes results from the transition state. 2 Enzymatic catalysis The reduction of activation energy results from its efficient binding by the enzyme. Substrates and products are associated with significantly lower energy. Transition state analogues Transition state analogues – compounds exhibiting structural and electronic features similar to the transion state. Enzymes bind "transition state", NO substrates or products transition state analogues are associated with much higher energy compared to substrates / Transition state analogues products and their analogues. are good inhibitors. 3 Transition state vs intermediate The mechanism of the amide bond hydrolysis reaction usually involves two transition states. Transition state analogues Advantages: high binding energy - high inhibitory activity; high specificity; simple design with a known transition state structure. Disadvantages: the enzymatic reaction mechanism is not always known; it is often very difficult to determine the structure of the transition state; Transition state analogs do not always have the characteristics necessary for the drug (pharmacokinetics, farmocodynamics, etc.).
    [Show full text]
  • Purification and Partial Characterization of Arginine Decarboxylase from Rice Embryos (Oryza Sativa
    Agric. Biol. Chem., 46 (3), 739-743, 1982 739 Purification and Partial Characterization of Arginine Decarboxylase from Rice Embryos (Oryza sativa L.) Murari Mohan Choudhuri and Bharati Ghosh Plant Physiology Laboratory, Botany Department, Bose Institute, Calcutta-700009, West Bengal, India Received July 30, 1981 Arginine decarboxylase (E.C. 4.1.1) after purification from rice seedlings was separated into fractions A (MW88000) and B (MW174000) by gel chromatography. Fraction B was much more active than A. After DEAEcellulose chromatography, the active fraction of the enzyme (B) was purified to homogeneity, which appeared as a single band in gel electrophoresis. The optimal pH and temperature for the enzyme were8.0 and 45°C, respectively. The enzyme followed typical Michaelis-Menten kinetics with a Kmvalue of 0.28mM. It had no dependence on a metal, and consisted of 16 amino acids of which proline was prominent. Pyridoxal-5-phosphate acted as a co- factor of the enzyme. The enzyme activity was inhibited by various amines and inhibitors, of which the highest inhibition was obtained with spermine and hydroxylamine. The plant hormones played a vital role in regulating the activity of the enzyme which was promoted by kinetin and inhibited by abscisic acid. The diamine, putrescine, serves as the obli- MATERIALS AND METHODS gatory precursor of polyamines, spermidine Chemicals. L-[U-14C] Arginine (Spec. act. 66 mCi/mmol) and spermine.1'2) In animals, bacteria and cer- was purchased from Bhaba Atomic Research Centre tain plants, putrescine is formed from or- (Trombay, Bombay, India). Sepharose 4B and DEAE- nithine by ornithine decarboxylase, a rate cellulose are the products of Sigma Chemical Co.
    [Show full text]
  • Effects of Amino Acid Decarboxylase Genes and Ph on the Amine Formation of Enteric Bacteria from Chinese Traditional Fermented Fish (Suan Yu)
    fmicb-11-01130 July 2, 2020 Time: 13:3 # 1 ORIGINAL RESEARCH published: 02 July 2020 doi: 10.3389/fmicb.2020.01130 Effects of Amino Acid Decarboxylase Genes and pH on the Amine Formation of Enteric Bacteria From Chinese Traditional Fermented Fish (Suan Yu) Qin Yang1,2,3, Ju Meng1,2,3, Wei Zhang4, Lu Liu1,2,3, Laping He1,2,3, Li Deng1,2,3, Xuefeng Zeng1,2,3* and Chun Ye1,2,3* 1 School of Liquor and Food Engineering, Guizhou University, Guiyang, China, 2 Guizhou Provincial Key Laboratory of Agricultural and Animal Products Storage and Processing, Guiyang, China, 3 Key Laboratory of Animal Genetics, Breeding and Reproduction in the Plateau Mountainous Region, Ministry of Education, Guiyang, China, 4 College of Food Science and Engineering, Wuhan Polytechnic University, Wuhan, China The formation of biogenic amines (BAs) is an important potential risk in Suan yu. This study investigated the amine production abilities of 97 strains of enteric bacteria screened from Suan yu. The genotypic diversity of amino acid decarboxylase and the effect of pH were explored on 27 strains of high-yield BAs. Results showed that high Edited by: levels of putrescine, histamine, and cadaverine were produced by the 97 strains. In Giovanna Suzzi, addition, 27 strains carried odc, speA, speB, adiA, and ldc genes. Thirteen carried hdc University of Teramo, Italy gene. Morganella morganii 42C2 produced the highest putrescine content of 880 mg/L Reviewed by: Giorgia Perpetuini, via the ornithine decarboxylase pathway. The highest histamine content was produced University of Teramo, Italy by Klebsiella aerogenes 13C2 (1,869 mg/L).
    [Show full text]